New data from the first Danish Interventional Study done in Hillerød University Hospital in Denmark and based on 6000 patients was presented at the 6´th Danish Emergency Medicine Conference in November, 2014.

This year ViroGates will be present as exhibitor at DEMC6 - the 6th Danish Emergency Medicine Conference.
The congress is taking place in Odense, Denmark on November 20-21.

Come and get a demo of the suPARnostic® Quick Triage product!

2nd edition of the suPARnostic® Quick Triage test device has been launched and is now available for sale.
It has been validated on the Quick Test Reader and is living up to the standards of CE IVD.

This year ViroGates will be present as exhibitor at EuSEM 2014 - the 8th European Congress on Emergency Medicine.
The congress is taking place in Amsterdam from September 28 - October 1.

Come join us at booth # 24, and get a demo of the suPARnostic® Quick Triage product!

The Danish newspapers Berlingske Tidende and BT has published a 16-page guide under the title "Blood test can save lives".

The 5´th International suPAR Symposium was successfully held in Amsterdam, The Netherlands on May 8-9, 2014.

In June 2014, The European Science Open Festival, also called ESOF, was held in Copenhagen, Denmark.

The cooperation between ViroGates and Copenhagen University Hospital Hvidovre, Denmark, is based on research started at Hvidovre Hospital in 1999. The amount of the protein suPAR in the blood was found to be a general marker for risk stratification of patients, indicating disease severity and monitoring patient survival.

New Austrian study shows that the biomarker suPAR is able to predict mortality for patients at a very early stage of blood poisoning [sepsis/SIRS]. These findings demonstrate again that suPARnostic® is superior to other wellknown biomarker products used today upon admission to the Emergency Department.

ViroGates has signed up with a new distributor in Norway: